Search results - ORA - Oxford University Research Archive

1 - 17 of 17

1

Journal article

Fully automated radiosynthesis of N1-[18F]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imaging

Henrottin, J, Lemaire, C, Egrise, D, et al.
2016-03-11

2

Conference item

Indoleamine 2,3 dioxygenase activity aggravates the course and pathology of murine tuberculosis

Guo, L, Van Der Sluijs, K, Van Der Windt, G, et al.
2018-05-24

3

Journal article

Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications

Mandarano, M, Bellezza, G, Belladonna, M, et al.
2018-11-17

4

Journal article

Induction of tryptophan 2,3-dioxygenase expression in human monocytic leukemia/lymphoma cell lines THP-1 and U937

Hoffmann, D, Pilotte, L, Stroobant, V, et al.
2019-12-26

5

Journal article

The vacuolar pathway of long peptide cross-presentation can be TAP dependent

Ma, W, Stroobant, V, Heirman, C, et al.
2019-01-15

6

Journal article

Overexpression of ubiquitin-specific peptidase 15 in systemic sclerosis fibroblasts increases response to transforming growth factor β

Galant, C, Marchandise, J, Stoenoiu, MS, et al.
2019-01-03

7

Conference item

Single cell RNA sequencing reveals AML immunoediting under pressure from engineered T cell therapy

Paulson, K, Schmitt, T, Egan, D, et al.
2018-07-31

8

Journal article

Characterization of the selective indoleamine 2,3-dioxygenase-1 (IDO1) catalytic inhibitor EOS200271/PF-06840003 supports IDO1 as a critical resistance mechanism to PD-(L)1 blockade therapy

Gomes, B, Driessens, G, Bartlett, D, et al.
2018-09-19

9

Conference item

Immunosuppression mediated by enzymes that degrade tryptophan

Van Den Eynde, B
2018-09-12

10

Journal article

Microenvironment tumor metabolic interactions highlighted by qMSI: Application to the tryptophan-kynurenine pathway in immuno-oncology

Ait-Belkacem, R, Bol, V, Hamm, G, et al.
2017-05-30

11

Conference item

The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model

Krendyukov, A, Kneisel, N, Zhu, J, et al.
2020-01-13

12

Journal article

Cytosolic processing governs TAP-independent presentation of a critical melanoma antigen

Vigneron, N, Ferrari, V, Van Den Eynde, B, et al.
2018-08-22

13

Journal article

Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism

Zhu, J, Petit, P, Van Den Eynde, B
2018-11-07

14

Journal article

Discovery of a novel and selective Indoleamine 2,3-Dioxygenase (IDO-1) inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and its characterization as a potential clinical candidate

Crosignani, S, Bingham, P, Bottemanne, P, et al.
2017-11-07

15

Journal article

Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors

Schramme, F, Crosignani, S, Frederix, K, et al.
2019-12-05

16

Journal article

Loss of IDO1 expression from human pancreatic β-cells precedes their destruction during the development of type 1 diabetes

Anquetil, F, Mondanelli, G, Gonzalez, N, et al.
2018-06-26

17

Thesis

Haploid genetic screening approach towards identifying novel regulators of immune checkpoints

Chandrasekar, V
2021

TO TOP